Leis-Filho, A.F.; de Faria Lainetti, P.; Emiko Kobayashi, P.; Fonseca-Alves, C.E.; Laufer-Amorim, R.
Effects of Lapatinib on HER2-Positive and HER2-Negative Canine Mammary Carcinoma Cells Cultured In Vitro. Pharmaceutics 2021, 13, 897.
https://doi.org/10.3390/pharmaceutics13060897
AMA Style
Leis-Filho AF, de Faria Lainetti P, Emiko Kobayashi P, Fonseca-Alves CE, Laufer-Amorim R.
Effects of Lapatinib on HER2-Positive and HER2-Negative Canine Mammary Carcinoma Cells Cultured In Vitro. Pharmaceutics. 2021; 13(6):897.
https://doi.org/10.3390/pharmaceutics13060897
Chicago/Turabian Style
Leis-Filho, Antonio Fernando, PatrÃcia de Faria Lainetti, Priscila Emiko Kobayashi, Carlos Eduardo Fonseca-Alves, and Renée Laufer-Amorim.
2021. "Effects of Lapatinib on HER2-Positive and HER2-Negative Canine Mammary Carcinoma Cells Cultured In Vitro" Pharmaceutics 13, no. 6: 897.
https://doi.org/10.3390/pharmaceutics13060897
APA Style
Leis-Filho, A. F., de Faria Lainetti, P., Emiko Kobayashi, P., Fonseca-Alves, C. E., & Laufer-Amorim, R.
(2021). Effects of Lapatinib on HER2-Positive and HER2-Negative Canine Mammary Carcinoma Cells Cultured In Vitro. Pharmaceutics, 13(6), 897.
https://doi.org/10.3390/pharmaceutics13060897